Skip to main content

stock

BJDX · Bluejay Diagnostics, Inc.

What Bluejay Diagnostics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live BJDX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BJDX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
4,468,051 as of 2026-08-07 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-77.2%
ROA
-63.0%

Health

Current ratio
4.6x
Debt/equity
—

Deep value

NCAV
$7.70M
NCAV per share
$1.72
Price/NCAV
Locked
NNWC
$7.48M
NNWC per share
$1.67
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$2.35M-$2.32M
10-Q filed 2026-08-12
2026-03-31——-$1.94M-$1.92M
10-Q filed 2026-08-12
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——-$1.46M-$1.43M
10-K filed 2026-03-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——-$1.62M-$1.60M
10-Q filed 2025-11-07
2025-06-30——-$1.99M-$1.96M
10-Q filed 2026-08-12
2025-03-31——-$1.89M-$1.86M
10-Q filed 2026-08-12
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——-$1.48M-$1.43M
10-K filed 2026-03-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——-$1.36M-$1.48M
10-Q filed 2025-11-07
Assets
$11.53M
Equity
$9.41M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$6.95M-$6.85M-$6.23M
2024-12-31—-$7.17M-$7.72M-$8.13M
2023-12-31—-$10.31M-$9.95M-$9.02M
2022-12-31$249,040-$9.32M-$9.30M-$8.94M
2021-12-31—-$3.23M-$3.49M-$4.39M
2020-12-31—-$1.20M-$1.16M—

Company filings

since Wed Jun 17 · 2 offering filings in 12 months

events

  • Regulation FD disclosure

    Regulation FD disclosure
    Oct 68-K
  • Material agreement, Regulation FD disclosure

    Material agreementRegulation FD disclosure
    Sep 88-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Aug 138-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Jul 228-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    Jun 98-K
  • Material agreement, Unregistered share sale, Other event

    Material agreementUnregistered share saleOther event
    Jun 88-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • HRT FINANCIAL LP

    10% owner

    Sale$48,913

    Jul 13, 3:14 PM ET

  • HRT FINANCIAL LP

    10% owner

    Buy$96,711

    Jul 13, 3:14 PM ET

All insider trades for BJDX

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named BJDX, and the market events around them.

Sign in to see this

Board

The BJDX board could not be loaded.

Retry the BJDX board

nakagai

Signals on BJDX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BJDX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Bluejay Diagnostics, Inc. (BJDX): SEC filings, financials and insider trades · Nakagai